These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group. Eur J Cancer Clin Oncol; 1985 Jan; 21(1):143-6. PubMed ID: 4038653 [No Abstract] [Full Text] [Related]
17. Promising new therapies for malignant gliomas. Fine HA Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of tumors of the central nervous system]. Hildebrand J Rev Med Brux; 1987 Apr; 8(4):195-8. PubMed ID: 3589267 [No Abstract] [Full Text] [Related]
19. New developments in the treatment of malignant gliomas. Soffietti R; Leoncini B; Rudà R Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas. Kaplan RS; Smiley JK; Cheson BD Oncology (Williston Park); 1999 Apr; 13(4):532-3, 537. PubMed ID: 10234703 [No Abstract] [Full Text] [Related] [Next] [New Search]